(ADDV-B) ADDvise - Ratings and Ratios

ADDvise Group AB (publ) is a diversified healthcare company that supplies a broad range of medical devices, equipment, and consumables to various sectors, including laboratories, research facilities, healthcare providers, and pharmaceutical companies across multiple regions. The companys product portfolio encompasses laboratory infrastructure, medical equipment, and consumables for various medical specialties, as well as services such as designing and installing cleanrooms and air conditioning systems.

The companys business model is characterized by a diverse range of products and services that cater to different segments of the healthcare industry, including life sciences, biopharma, and medical device markets. ADDvises offerings include medical equipment for urology, gynecology, emergency care, and surgery, as well as implants, instruments, and technologies for surgical precision. The company also develops and markets products for rescue, ambulance, healthcare, and rehabilitation operations, and supplies glucose monitors and insulin pumps for diabetic patients.

From a market perspective, the global medical device and equipment market is expected to continue growing, driven by an aging population, increasing healthcare spending, and advancements in medical technology. ADDvise is well-positioned to capitalize on these trends, given its diverse product and service offerings, as well as its presence in multiple regions. The companys focus on life sciences and biopharma sectors, which are expected to experience significant growth, could also contribute to its future success.

Analyzing the , we can observe that the stock has been trading around its 20-day simple moving average (SMA20) of 1.72, with a 50-day SMA of 1.53, indicating a potential bullish crossover. The 200-day SMA is at 3.06, suggesting that the stock is currently underperforming its long-term trend. The average true range (ATR) is 0.13, or 7.63% of the current price, indicating moderate volatility. Based on these technical indicators, we can forecast a potential price movement towards the 50-day SMA, potentially followed by a breakout above the 20-day SMA, targeting a level around 2.00-2.20.

From a fundamental perspective, the companys market capitalization is 531.86M SEK, with a price-to-earnings (P/E) ratio of 15.36 and a forward P/E of 10.91, indicating a relatively reasonable valuation. The return on equity (RoE) is 9.12, suggesting that the company is generating a decent return on shareholders equity. Combining the fundamental and technical analysis, we forecast that ADDV-B could potentially experience a price increase in the short to medium term, driven by the companys diversified business model, growing demand for medical devices and equipment, and potential technical breakout. A target price of 2.50-3.00 could be achievable within the next 6-12 months, representing a potential upside of 45-75% from the current price.